These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3108254)

  • 1. The factor IX phospholipid-binding site is required for calcium-dependent activation of factor IX by factor XIa.
    Liebman HA; Furie BC; Furie B
    J Biol Chem; 1987 Jun; 262(16):7605-12. PubMed ID: 3108254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of the N-terminus of human factor IX by defective propeptide cleavage or acetylation results in a destabilized calcium-induced conformation: effects on phospholipid binding and activation by factor XIa.
    Wojcik EG; Van Den Berg M; Poort SR; Bertina RM
    Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):629-36. PubMed ID: 9169594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prothrombin requires two sequential metal-dependent conformational transitions to bind phospholipid. Conformation-specific antibodies directed against the phospholipid-binding site on prothrombin.
    Borowski M; Furie BC; Bauminger S; Furie B
    J Biol Chem; 1986 Nov; 261(32):14969-75. PubMed ID: 2429962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metal-dependent conformational changes in factor IX associated with phospholipid binding. Studies using antibodies against a synthetic peptide and chemical modification of factor IX.
    Liebman HA
    Eur J Biochem; 1993 Mar; 212(2):339-45. PubMed ID: 7680311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional domains in the heavy-chain region of factor XI: a high molecular weight kininogen-binding site and a substrate-binding site for factor IX.
    Baglia FA; Sinha D; Walsh PN
    Blood; 1989 Jul; 74(1):244-51. PubMed ID: 2665835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane binding properties of the factor IX gamma-carboxyglutamic acid-rich domain prepared by chemical synthesis.
    Jacobs M; Freedman SJ; Furie BC; Furie B
    J Biol Chem; 1994 Oct; 269(41):25494-501. PubMed ID: 7929250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrogen-deuterium exchange mass spectrometry highlights conformational changes induced by factor XI activation and binding of factor IX to factor XIa.
    Bar Barroeta A; van Galen J; Stroo I; Marquart JA; Meijer AB; Meijers JCM
    J Thromb Haemost; 2019 Dec; 17(12):2047-2055. PubMed ID: 31519061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profactor IX: the propeptide inhibits binding to membrane surfaces and activation by factor XIa.
    Bristol JA; Freedman SJ; Furie BC; Furie B
    Biochemistry; 1994 Nov; 33(47):14136-43. PubMed ID: 7947825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of residues in the Gla-domain of human factor IX involved in the binding to conformation specific antibodies.
    Wojcik EG; Cheung WF; van den Berg M; van der Linden IK; Stafford DW; Bertina RM
    Biochim Biophys Acta; 1998 Jan; 1382(1):91-101. PubMed ID: 9507074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of calcium ions and the heavy chain of factor XIa in the activation of human coagulation factor IX.
    Sinha D; Seaman FS; Walsh PN
    Biochemistry; 1987 Jun; 26(13):3768-75. PubMed ID: 3498513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivity of bovine blood coagulation factor IXa beta, factor Xa beta, and factor XIa toward fluorogenic peptides containing the activation site sequences of bovine factor IX and factor X.
    Castillo MJ; Kurachi K; Nishino N; Ohkubo I; Powers JC
    Biochemistry; 1983 Mar; 22(5):1021-9. PubMed ID: 6601494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor IX Zutphen: a Cys18-->Arg mutation results in formation of a heterodimer with alpha 1-microglobulin and the inability to form a calcium-induced conformation.
    Wojcik EG; van den Berg M; van der Linden IK; Poort SR; Cupers R; Bertina RM
    Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):753-9. PubMed ID: 7487929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assembly and expression of an intrinsic factor IX activator complex on the surface of cultured human endothelial cells.
    Berrettini M; Schleef RR; Heeb MJ; Hopmeier P; Griffin JH
    J Biol Chem; 1992 Oct; 267(28):19833-9. PubMed ID: 1400299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterization of human blood coagulation factor XIa using hybridoma antibodies.
    Sinha D; Koshy A; Seaman FS; Walsh PN
    J Biol Chem; 1985 Sep; 260(19):10714-9. PubMed ID: 3875611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperative Ca2+ binding to human factor IX. Effects of Ca2+ on the kinetic parameters of the activation of factor IX by factor XIa.
    Bajaj SP
    J Biol Chem; 1982 Apr; 257(8):4127-32. PubMed ID: 6978337
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulation of the tertiary structure and function of coagulation factor IX by magnesium (II) ions.
    Sekiya F; Yamashita T; Atoda H; Komiyama Y; Morita T
    J Biol Chem; 1995 Jun; 270(24):14325-31. PubMed ID: 7782291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanism underlying activation of factor IX by factor XIa.
    Gailani D; Geng Y; Verhamme I; Sun MF; Bajaj SP; Messer A; Emsley J
    Thromb Res; 2014 May; 133 Suppl 1(0 1):S48-51. PubMed ID: 24759143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macromolecular substrate-binding exosites on both the heavy and light chains of factor XIa mediate the formation of the Michaelis complex required for factor IX-activation.
    Sinha D; Marcinkiewicz M; Navaneetham D; Walsh PN
    Biochemistry; 2007 Aug; 46(34):9830-9. PubMed ID: 17676929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and chemical synthesis of a substrate-binding site for factor IX on coagulation factor XIa.
    Baglia FA; Jameson BA; Walsh PN
    J Biol Chem; 1991 Dec; 266(35):24190-7. PubMed ID: 1748688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sequential mechanism for exosite-mediated factor IX activation by factor XIa.
    Geng Y; Verhamme IM; Messer A; Sun MF; Smith SB; Bajaj SP; Gailani D
    J Biol Chem; 2012 Nov; 287(45):38200-9. PubMed ID: 22961984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.